| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again | Ben Fidler | 02/14/19 | National |
| 15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) | Ben Fidler | 12/17/18 | National |
| Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel | Ben Fidler | 11/09/18 | National |
| Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More | Ben Fidler | 08/10/18 | National |
| Ultragenyx Sweetens Offer, Dimension Tx Agrees to $151M Acquisition | Frank Vinluan | 10/03/17 | San Francisco |
| Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More | Ben Fidler | 09/22/17 | National |
| Ultragenyx Makes Competing Bid for Gene Therapy Biotech Dimension Tx | Frank Vinluan | 09/18/17 | San Francisco |
| Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More | Alex Lash | 09/01/17 | National |
| RegenxBio to Acquire Dimension Tx in Combo of Gene Therapy Companies | Frank Vinluan | 08/25/17 | Boston |
| For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY | Ben Fidler | 08/09/17 | New York |
| Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval | Ben Fidler | 07/20/16 | San Francisco |
| Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance | Ben Fidler | 05/16/16 | Boston |
| With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist | Ben Fidler | 05/02/16 | Boston |
| Biogen Helps Put $42.5M Into a Father’s Duchenne Gene Therapy Quest | Ben Fidler | 11/05/15 | Boston |
| Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO | Ben Fidler | 10/21/15 | Boston |
| Voyager Charts an IPO Course Amid Choppy Biotech Waters | Ben Fidler | 10/11/15 | Boston |
| No Drug Yet In Clinic, But CytomX Raises $80M In Discounted IPO | Alex Lash | 10/08/15 | San Francisco |
| Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO | Ben Fidler | 09/28/15 | San Francisco |
| East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More | Ben Fidler | 09/21/15 | Boston |
| Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue | Ben Fidler | 09/14/15 | Boston |
| In Biotech, Everyone’s Going Public. What’s Your Excuse? | Alex Lash | 07/22/15 | National |
| East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More | Ben Fidler | 04/24/15 | Boston |
